Table 3.

Outcome and patient characteristics according to number of joint bleeds until start of prophylaxis

No. of joint bleeds until start of prophylaxisLess than 33-1415-4445 or more
Patients     
 No. 10 11 13 
 Age at last Pettersson score, y 15.8  (14.1-17.0) 17.5  (13.9-20.8) 17.2  (14.3-22.9) 22.3  (16.2-26.6)  
 Age at first joint bleed, y 1.0  (1.0-1.3) 1.4  (0.8-3.5) 2.4  (1.8-2.7) 3.0  (2.3-3.7)  
Treatment     
 Age at start of prophylaxis, y 1.4  (1.1-2.6) 4.1  (2.4-5.0) 5.6  (5.1-6.9) 8.7  (8.3-16.7)  
 Lag time, y − 0.2  (−1.8-+ 0.3) 1.6  (1.4-2.6) 3.5  (2.6-4.6) 7.1  (4.8-13.7)  
 No. of joint bleeds until prophylaxis 0.5  (0-1) 11  (7-13) 32  (24-42) 100  (81-132) 
Outcome     
 Last Pettersson score (maximum 78) 0  (0-2) 5  (3-13) 7  (0-17) 8  (4-14)  
 Pts with last Pettersson above 0, % 30 82 69 78 
 Clinical score (maximum 90)3-150 0  (0-1) 2  (0-5) 4  (1-6) 4  (0-5)  
 Pts with clinical score above 0, % 30 73 77 67 
No. of joint bleeds until start of prophylaxisLess than 33-1415-4445 or more
Patients     
 No. 10 11 13 
 Age at last Pettersson score, y 15.8  (14.1-17.0) 17.5  (13.9-20.8) 17.2  (14.3-22.9) 22.3  (16.2-26.6)  
 Age at first joint bleed, y 1.0  (1.0-1.3) 1.4  (0.8-3.5) 2.4  (1.8-2.7) 3.0  (2.3-3.7)  
Treatment     
 Age at start of prophylaxis, y 1.4  (1.1-2.6) 4.1  (2.4-5.0) 5.6  (5.1-6.9) 8.7  (8.3-16.7)  
 Lag time, y − 0.2  (−1.8-+ 0.3) 1.6  (1.4-2.6) 3.5  (2.6-4.6) 7.1  (4.8-13.7)  
 No. of joint bleeds until prophylaxis 0.5  (0-1) 11  (7-13) 32  (24-42) 100  (81-132) 
Outcome     
 Last Pettersson score (maximum 78) 0  (0-2) 5  (3-13) 7  (0-17) 8  (4-14)  
 Pts with last Pettersson above 0, % 30 82 69 78 
 Clinical score (maximum 90)3-150 0  (0-1) 2  (0-5) 4  (1-6) 4  (0-5)  
 Pts with clinical score above 0, % 30 73 77 67 

Values are numbers or medians (IQR: 25th and 75th percentiles).

F3-150

The clinical score was assessed within 1 year of the last Pettersson score.

Close Modal

or Create an Account

Close Modal
Close Modal